Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients

Transfusion

Volumn 43, Issue 3, 2003, Pages 309-313

  Drew, W Lawrence ^a   Tegtmeier, Gary ^b   Alter, Harvey J ^b   Laycock, Megan E ^b   Miner, Richard C ^b   Busch, Michael P ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANTIBODY TITER; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CYTOMEGALOVIRUS INFECTION; ENZYME IMMUNOASSAY; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; SEROCONVERSION; VIREMIA;

ANTIBODIES, VIRAL; BLOOD DONORS; BLOOD TRANSFUSION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HUMANS; POLYMERASE CHAIN REACTION; VIREMIA;

EID: 0037346003     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00337.x     Document Type: Article

References (19)

1. Luthardt T, Siebert H, Losel I, et al. Cytomegalovirus infections in infants with blood exchange transfusions after birth. Klin Wochenschr 1971;49:81-6.
2. Yeager AS, Grumet FC, Hafleigh EB, et al. Prevention of transfusion-acquired cytomegalovirus infections in new-born infants. J Pediatr 1981;98:281-7.
3. Bowden RA, Sayers M, Fournoy N, et al. Cytomegalovirus immne globulin and seronegative products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986;314:1006-10.
4. MacKinnon S, Burnett AK, Crawford RJ, et al. Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation. J Clin Pathol 1988;41:948-50.
5. Miller WJ, McCullough J, Balfour HH Jr., et al. Prevention of cytomegaloirus infection following bone marrow transplantation: a randomized trial of blood product screening. Bone Marrow Transplant 1991;7:227-34.
6. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) sereonegative blood products for the prevention of transfusion-associated CMV infection after bone marrow transplant. Blood 1995;86:3598-603.
7. Laupacis A, Brown J, Costello B, et al. Prevention of post-transfusion CMV in the era of universal WBC reduction: a consensus statement. Transfusion 2001;41:560-9.
8. Dykewicz CA. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis 2001;33:139-44.
9. Caliendo AM, Schuurman R, Yen-Lieberman B, et al. Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J Clin Microbiol 2001;39:1334-8.
10. Waner JL, Weller TH, Kevy SV. Patterns of cytomegalovirus complement fixing antibody activity: a longitudinal study of blood donors. J Infect Dis 1973;127:538-43.
11. Revello MG, Zavattoni M, Sarasini A, et al. Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J Infect Dis 1998;177:1170-5.
12. Zanghellini F, Boppana SB, Emery V, et al. Asymptomatic primary cytomegalovirus infection: virologic and immunolgic features. J Infect Dis 1999;180:702-7.
13. Slobedman B, Mocarski ES. Quantitative analysis of latent human cytomegalovirus. J Virol 1999;73:4806-12.
14. Lipson SM, Shepp DH, Match ME, et al. Cytomegalovirus infectivity in whole blood following leukocyte reduction by filtration. Am J Clin Pathol 2001;116:52.
15. Bevan IS, Daw RA, Day PJ, et al. Polymerase chain reaction for detection of human cytomegalovirus infections in a blood donor population. Br J Haematol 1991;78:94-9.
16. Taylor-Wiedman J, Sissons JG, Borysiewicz LK, et al. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991;72:2059-64.
17. Larsson S, Soderberg-Naucler C, Wang FZ, et al. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion 1998;38:271-8.
18. Roback JD, Hillyer CD, Drew WL, et al. Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors. Transfusion 2001;41:1249-57.
19. Dumont LL, Luka J, VandenBroeke T, et al. The effect of leukocyte-reduction method on the amount of human cytomegalovirus in blood products: a comparison of apheresis and filtration methods. Blood 2001;97:3640-7.